Preoperative Amiodarone and Primary Graft Dysfunction in Heart Transplantation.

Abigail M ServaisScott LundgrenStephanie BowmanDouglas StollerAdam BurdorfMarshall HydenBrian LowesRonald ZoltyDon KlepserHeidi Brink

Published in: The Annals of pharmacotherapy (2024)

A trend toward increased PGD was present in patients receiving preoperative amiodarone. This finding combined with the regression showing significantly increased odds of PGD with increasing 3 and 6 month cumulative amiodarone dose is clinically concerning. Escalation of care with pacemaker implantation was required more frequently in patients on pre-OHT amiodarone.

Keyphrases

end stage renal disease
patients undergoing
healthcare
newly diagnosed
chronic kidney disease
palliative care
peritoneal dialysis
prognostic factors
oxidative stress
randomized controlled trial
open label
patient reported outcomes
inferior vena cava
affordable care act